Molecular Basis of Cardioprotection by Erythropoietin

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 56-69

Bentham Science Publishers

Access to resources Recommend Favorite

Cardioprotection by Recombinant Human Erythropoietin Following Acute Experimental Myocardial Infarction: Dose Response and Therapeutic Window

By Moon Chanil   Krawczyk Melissa   Paik Doojin   Lakatta Edward   Talan Mark  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 4, 2005-08 ,pp. : 243-250

Springer Publishing Company

Access to resources Recommend Favorite

Erythropoietin (EPO) Affords More Potent Cardioprotection by Activation of Distinct Signaling to Mitochondrial Kinases Compared with Carbamylated EPO

By Sato Takahiro   Tanno Masaya   Miki Takayuki   Yano Toshiyuki   Sato Tatsuya   Shimamoto Kazuaki   Miura Tetsuji  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 401-408

Springer Publishing Company

Access to resources Recommend Favorite

Cardioprotection in the Clinical Setting-Lessons from J-WIND Studies

By Asakura Masanori   Kitakaze Masafumi  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 3, 2010-06 ,pp. : 289-295

Springer Publishing Company

Access to resources Recommend Favorite

Anesthetic Cardioprotection in Clinical Practice From Proof-of-Concept to Clinical Applications

By  

Current Pharmaceutical Design, Vol. 20, Iss. 36, 2014-11 ,pp. : 5706-5726

Bentham Science Publishers

Access to resources Recommend Favorite